{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T09:29:21Z","timestamp":1786613361930,"version":"build-2736575974"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["U19NS132296"],"award-info":[{"award-number":["U19NS132296"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R35GM119644"],"award-info":[{"award-number":["R35GM119644"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-76350-5","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T09:02:16Z","timestamp":1786611736000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genome-wide CRISPR screening identifies cellular factors controlling nonviral genome editing efficiency"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-0012-1673","authenticated-orcid":false,"given":"Shivani","family":"Saxena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meha","family":"Kabra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4071-6620","authenticated-orcid":false,"given":"Amr A.","family":"Abdeen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana M.","family":"Tabima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5854-0056","authenticated-orcid":false,"given":"Divya","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9233-9700","authenticated-orcid":false,"given":"Piper A.","family":"Rawding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0249-0002","authenticated-orcid":false,"given":"Ruosen","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanvi","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni M.","family":"Hanstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A.","family":"Fernandez Zepeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8152-613X","authenticated-orcid":false,"given":"David M.","family":"Gamm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5385-358X","authenticated-orcid":false,"given":"Bikash R.","family":"Pattnaik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9447-2938","authenticated-orcid":false,"given":"Shaoqin","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2837-0858","authenticated-orcid":false,"given":"Krishanu","family":"Saha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,13]]},"reference":[{"key":"76350_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/s41591-018-0327-9","volume":"25","author":"ML Maeder","year":"2019","unstructured":"Maeder, M. L. et al. Development of a gene-editing approach to restore vision loss in Leber congenital amaurosis type 10. Nat. Med. 25, 229\u2013233 (2019).","journal-title":"Nat. Med."},{"key":"76350_CR2","doi-asserted-by":"publisher","DOI":"10.1126\/science.aba7365","volume":"367","author":"EA Stadtmauer","year":"2020","unstructured":"Stadtmauer, E. A. et al. CRISPR-engineered T cells in patients with refractory cancer. Science 367, eaba7365 (2020).","journal-title":"Science"},{"key":"76350_CR3","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/s41573-023-00762-x","volume":"22","author":"V Madigan","year":"2023","unstructured":"Madigan, V., Zhang, F. & Dahlman, J. E. Drug delivery systems for CRISPR-based genome editors. Nat. Rev. Drug Discov. 22, 875\u2013894 (2023).","journal-title":"Nat. Rev. Drug Discov."},{"key":"76350_CR4","doi-asserted-by":"publisher","unstructured":"Ledford, H. CRISPR genome-editing grows up: advanced therapies head for the clinic. Nature https:\/\/doi.org\/10.1038\/d41586-024-04102-w (2024).","DOI":"10.1038\/d41586-024-04102-w"},{"key":"76350_CR5","doi-asserted-by":"publisher","unstructured":"Frangoul, H. et al. CRISPR-Cas9 gene editing for sickle cell disease and \u03b2-thalassemia. Yearb. Pediatr. Endocrinol. https:\/\/doi.org\/10.1530\/ey.18.14.4 (2021).","DOI":"10.1530\/ey.18.14.4"},{"key":"76350_CR6","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.ymthe.2024.01.015","volume":"32","author":"A Leonard","year":"2024","unstructured":"Leonard, A. & Tisdale, J. F. A new frontier: FDA approvals for gene therapy in sickle cell disease. Mol. Ther. 32, 264\u2013267 (2024).","journal-title":"Mol. Ther."},{"key":"76350_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/hum.2023.29263.bfs","volume":"35","author":"A Philippidis","year":"2024","unstructured":"Philippidis, A. CASGEVY makes history as FDA approves first CRISPR\/Cas9 genome edited therapy. Hum. Gene Ther. 35, 1\u20134 (2024).","journal-title":"Hum. Gene Ther."},{"key":"76350_CR8","doi-asserted-by":"publisher","first-page":"2868","DOI":"10.1073\/pnas.1520244113","volume":"113","author":"M Wang","year":"2016","unstructured":"Wang, M. et al. Efficient delivery of genome-editing proteins using bioreducible lipid nanoparticles. Proc. Natl. Acad. Sci. USA 113, 2868\u20132873 (2016).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"76350_CR9","doi-asserted-by":"publisher","first-page":"5711","DOI":"10.1021\/acs.nanolett.7b02664","volume":"17","author":"S Patel","year":"2017","unstructured":"Patel, S. et al. Boosting intracellular delivery of lipid nanoparticle-encapsulated mRNA. Nano Lett. 17, 5711\u20135718 (2017).","journal-title":"Nano Lett."},{"key":"76350_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.crmeth.2022.100290","volume":"2","author":"T Haideri","year":"2022","unstructured":"Haideri, T. et al. Robust genome editing via modRNA-based Cas9 or base editor in human pluripotent stem cells. Cell Rep. Methods 2, 100290 (2022).","journal-title":"Cell Rep. Methods"},{"key":"76350_CR11","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1038\/s41587-023-02078-y","volume":"42","author":"M An","year":"2024","unstructured":"An, M. et al. Engineered virus-like particles for transient delivery of prime editor ribonucleoprotein complexes in vivo. Nat. Biotechnol. 42, 1526\u20131537 (2024).","journal-title":"Nat. Biotechnol."},{"key":"76350_CR12","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1038\/s41587-024-02467-x","volume":"43","author":"A Raguram","year":"2025","unstructured":"Raguram, A., An, M., Chen, P. Z. & Liu, D. R. Directed evolution of engineered virus-like particles with improved production and transduction efficiencies. Nat. Biotechnol. 43, 1635\u20131647 (2025).","journal-title":"Nat. Biotechnol."},{"key":"76350_CR13","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3390\/v11010028","volume":"11","author":"CL Xu","year":"2019","unstructured":"Xu, C. L., Ruan, M. Z. C., Mahajan, V. B. & Tsang, S. H. Viral delivery systems for CRISPR. Viruses 11, 28 (2019).","journal-title":"Viruses"},{"key":"76350_CR14","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1089\/crispr.2024.0010","volume":"7","author":"A Sharrar","year":"2024","unstructured":"Sharrar, A. et al. Viral delivery of compact CRISPR-Cas12f for gene editing applications. CRISPR J. 7, 150\u2013155 (2024).","journal-title":"CRISPR J."},{"key":"76350_CR15","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.cell.2020.03.023","volume":"181","author":"D Wang","year":"2020","unstructured":"Wang, D., Zhang, F. & Gao, G. CRISPR-based therapeutic genome editing: Strategies and in vivo delivery by AAV vectors. Cell 181, 136\u2013150 (2020).","journal-title":"Cell"},{"key":"76350_CR16","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/s41586-021-03191-1","volume":"592","author":"K Saha","year":"2021","unstructured":"Saha, K. et al. The NIH somatic cell genome editing program. Nature 592, 195\u2013204 (2021).","journal-title":"Nature"},{"key":"76350_CR17","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1056\/NEJMoa2107454","volume":"385","author":"JD Gillmore","year":"2021","unstructured":"Gillmore, J. D. et al. CRISPR-Cas9 in vivo gene editing for transthyretin amyloidosis. N. Engl. J. Med. 385, 493\u2013502 (2021).","journal-title":"N. Engl. J. Med."},{"key":"76350_CR18","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1002\/humu.22807","volume":"36","author":"BR Pattnaik","year":"2015","unstructured":"Pattnaik, B. R. et al. A novel KCNJ13 nonsense mutation and loss of Kir7.1 channel function causes Leber congenital amaurosis (LCA16). Hum. Mutat. 36, 720\u2013727 (2015).","journal-title":"Hum. Mutat."},{"key":"76350_CR19","doi-asserted-by":"publisher","DOI":"10.1101\/2023.09.14.557853","author":"X Pan","year":"2023","unstructured":"Pan, X. et al. CRISPR-Cas9 engineered extracellular vesicles for the treatment of dominant progressive hearing loss. bioRxivorg https:\/\/doi.org\/10.1101\/2023.09.14.557853 (2023).","journal-title":"bioRxivorg"},{"key":"76350_CR20","doi-asserted-by":"crossref","unstructured":"Kabra, M. et al. Nonviral base editing of KCNJ13 mutation preserves vision in a model of inherited retinal channelopathyy. J. Clin. Invest. 133, e171356 (2023).","DOI":"10.1172\/JCI171356"},{"key":"76350_CR21","doi-asserted-by":"publisher","first-page":"13594","DOI":"10.1021\/acsnano.3c02268","volume":"17","author":"R Palanki","year":"2023","unstructured":"Palanki, R. et al. Ionizable lipid nanoparticles for therapeutic base editing of congenital brain disease. ACS Nano 17, 13594\u201313610 (2023).","journal-title":"ACS Nano"},{"key":"76350_CR22","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/nbt.3298","volume":"33","author":"A Wittrup","year":"2015","unstructured":"Wittrup, A. et al. Visualizing lipid-formulated siRNA release from endosomes and target gene knockdown. Nat. Biotechnol. 33, 870\u2013876 (2015).","journal-title":"Nat. Biotechnol."},{"key":"76350_CR23","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/nbt.2612","volume":"31","author":"J Gilleron","year":"2013","unstructured":"Gilleron, J. et al. Image-based analysis of lipid nanoparticle-mediated siRNA delivery, intracellular trafficking and endosomal escape. Nat. Biotechnol. 31, 638\u2013646 (2013).","journal-title":"Nat. Biotechnol."},{"key":"76350_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12275-6","volume":"10","author":"M Maugeri","year":"2019","unstructured":"Maugeri, M. et al. Linkage between endosomal escape of LNP-mRNA and loading into EVs for transport to other cells. Nat. Commun. 10, 4333 (2019).","journal-title":"Nat. Commun."},{"key":"76350_CR25","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1167\/iovs.61.4.31","volume":"61","author":"S Hu","year":"2020","unstructured":"Hu, S. et al. In vivo CRISPR\/Cas9-mediated genome editing mitigates photoreceptor degeneration in a mouse model of X-linked retinitis pigmentosa. Invest. Ophthalmol. Vis. Sci. 61, 31 (2020).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"76350_CR26","doi-asserted-by":"publisher","unstructured":"Wang, C. et al. Inhibiting POLQ-mediated alternative NHEJ enhances CRISPR\/Cas9 mediated precise genome editing in CHO cells. bioRxiv https:\/\/doi.org\/10.1101\/2022.12.09.519421 (2022).","DOI":"10.1101\/2022.12.09.519421"},{"key":"76350_CR27","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1038\/nprot.2013.143","volume":"8","author":"FA Ran","year":"2013","unstructured":"Ran, F. A. et al. Genome engineering using the CRISPR-Cas9 system. Nat. Protoc. 8, 2281\u20132308 (2013).","journal-title":"Nat. Protoc."},{"key":"76350_CR28","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nbt.4021","volume":"36","author":"MD Canny","year":"2018","unstructured":"Canny, M. D. et al. Inhibition of 53BP1 favors homology-dependent DNA repair and increases CRISPR\u2013Cas9 genome-editing efficiency. Nat. Biotechnol. 36, 95\u2013102 (2018).","journal-title":"Nat. Biotechnol."},{"key":"76350_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04609-7","volume":"9","author":"S Riesenberg","year":"2018","unstructured":"Riesenberg, S. & Maricic, T. Targeting repair pathways with small molecules increases precise genome editing in pluripotent stem cells. Nat. Commun. 9, 2164 (2018).","journal-title":"Nat. Commun."},{"key":"76350_CR30","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/nature20565","volume":"540","author":"K Suzuki","year":"2016","unstructured":"Suzuki, K. et al. In vivo genome editing via CRISPR\/Cas9 mediated homology-independent targeted integration. Nature 540, 144\u2013149 (2016).","journal-title":"Nature"},{"key":"76350_CR31","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkz669","volume":"47","author":"S Riesenberg","year":"2019","unstructured":"Riesenberg, S. et al. Simultaneous precise editing of multiple genes in human cells. Nucleic Acids Res 47, e116 (2019).","journal-title":"Nucleic Acids Res"},{"key":"76350_CR32","doi-asserted-by":"publisher","first-page":"5653","DOI":"10.1016\/j.cell.2021.10.002","volume":"184","author":"JA Hussmann","year":"2021","unstructured":"Hussmann, J. A. et al. Mapping the genetic landscape of DNA double-strand break repair. Cell 184, 5653\u20135669.e25 (2021).","journal-title":"Cell"},{"key":"76350_CR33","doi-asserted-by":"publisher","first-page":"103461","DOI":"10.1016\/j.dnarep.2023.103461","volume":"123","author":"O Huynh","year":"2023","unstructured":"Huynh, O., Ruis, K., Montales, K. & Michael, W. M. NBS1 binds directly to TOPBP1 via disparate interactions between the NBS1 BRCT1 domain and the TOPBP1 BRCT1 and BRCT2 domains. DNA Repair (Amst.) 123, 103461 (2023).","journal-title":"DNA Repair (Amst.)"},{"key":"76350_CR34","doi-asserted-by":"publisher","first-page":"5003","DOI":"10.1093\/nar\/gkab269","volume":"49","author":"S Kumamoto","year":"2021","unstructured":"Kumamoto, S. et al. HPF1-dependent PARP activation promotes LIG3-XRCC1-mediated backup pathway of Okazaki fragment ligation. Nucleic Acids Res. 49, 5003\u20135016 (2021).","journal-title":"Nucleic Acids Res"},{"key":"76350_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11105-z","volume":"10","author":"TS Nambiar","year":"2019","unstructured":"Nambiar, T. S. et al. Stimulation of CRISPR-mediated homology-directed repair by an engineered RAD18 variant. Nat. Commun. 10, 3395 (2019).","journal-title":"Nat. Commun."},{"key":"76350_CR36","doi-asserted-by":"publisher","first-page":"4664","DOI":"10.1016\/j.molcel.2022.11.008","volume":"82","author":"O Belan","year":"2022","unstructured":"Belan, O. et al. POLQ seals post-replicative ssDNA gaps to maintain genome stability in BRCA-deficient cancer cells. Mol. Cell 82, 4664\u20134680.e9 (2022).","journal-title":"Mol. Cell"},{"key":"76350_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1010309","volume":"18","author":"JP Wells","year":"2022","unstructured":"Wells, J. P. et al. RAD18 opposes transcription-associated genome instability through FANCD2 recruitment. PLoS Genet 18, e1010309 (2022).","journal-title":"PLoS Genet"},{"key":"76350_CR38","doi-asserted-by":"publisher","unstructured":"Muvarak, N. et al. Table S2 from c-MYC generates repair errors via increased transcription of alternative-NHEJ factors, LIG3 and PARP1, in tyrosine kinase\u2013activated leukemias. Am. Assoc. Cancer Res. https:\/\/doi.org\/10.1158\/1541-7786.22514281.v1 (2023).","DOI":"10.1158\/1541-7786.22514281.v1"},{"key":"76350_CR39","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1158\/1541-7786.MCR-14-0422","volume":"13","author":"N Muvarak","year":"2015","unstructured":"Muvarak, N. et al. C-MYC generates repair errors via increased transcription of alternative-NHEJ factors, LIG3 and PARP1, in tyrosine kinase-activated leukemias. Mol. Cancer Res. 13, 699\u2013712 (2015).","journal-title":"Mol. Cancer Res."},{"key":"76350_CR40","doi-asserted-by":"publisher","first-page":"5635","DOI":"10.1016\/j.cell.2021.09.018","volume":"184","author":"PJ Chen","year":"2021","unstructured":"Chen, P. J. et al. Enhanced prime editing systems by manipulating cellular determinants of editing outcomes. Cell 184, 5635\u20135652.e29 (2021).","journal-title":"Cell"},{"key":"76350_CR41","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/s41586-018-0340-7","volume":"560","author":"SM Noordermeer","year":"2018","unstructured":"Noordermeer, S. M. et al. The shieldin complex mediates 53BP1-dependent DNA repair. Nature 560, 117\u2013121 (2018).","journal-title":"Nature"},{"key":"76350_CR42","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.cell.2014.09.029","volume":"159","author":"LA Gilbert","year":"2014","unstructured":"Gilbert, L. A. et al. Genome-scale CRISPR-mediated control of gene repression and activation. Cell 159, 647\u2013661 (2014).","journal-title":"Cell"},{"key":"76350_CR43","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.1093\/nar\/gky076","volume":"46","author":"T Harmsen","year":"2018","unstructured":"Harmsen, T., Klaasen, S., van de Vrugt, H. & te Riele, H. DNA mismatch repair and oligonucleotide end-protection promote base-pair substitution distal from a CRISPR\/Cas9-induced DNA break. Nucleic Acids Res. 46, 2945\u20132955 (2018).","journal-title":"Nucleic Acids Res"},{"key":"76350_CR44","doi-asserted-by":"publisher","first-page":"8476","DOI":"10.1073\/pnas.1921791117","volume":"117","author":"J Carvajal-Garcia","year":"2020","unstructured":"Carvajal-Garcia, J. et al. Mechanistic basis for microhomology identification and genome scarring by polymerase theta. Proc. Natl. Acad. Sci. USA 117, 8476\u20138485 (2020).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"76350_CR45","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.molcel.2018.11.031","volume":"73","author":"AM Chakrabarti","year":"2019","unstructured":"Chakrabarti, A. M. et al. Target-specific precision of CRISPR-mediated genome editing. Mol. Cell 73, 699\u2013713.e6 (2019).","journal-title":"Mol. Cell"},{"key":"76350_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13905","volume":"8","author":"A Bothmer","year":"2017","unstructured":"Bothmer, A. et al. Characterization of the interplay between DNA repair and CRISPR\/Cas9-induced DNA lesions at an endogenous locus. Nat. Commun. 8, 13905 (2017).","journal-title":"Nat. Commun."},{"key":"76350_CR47","doi-asserted-by":"crossref","unstructured":"Teixeira, K. L. D., Mao, L., Doench, J. & Laurie, G. W. Optimization and initiation of a genome-wide forward genetic death screen for the lacritin receptor complex using the brunello CRISPR\/Cas 9 sgRNA library. FASEB J. 32, 533\u2013547 (2018).","DOI":"10.1096\/fasebj.2018.32.1_supplement.533.47"},{"key":"76350_CR48","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/s11064-016-2030-x","volume":"42","author":"KA Na\u0142\u0119cz","year":"2017","unstructured":"Na\u0142\u0119cz, K. A. Solute carriers in the blood-brain barier: Safety in abundance. Neurochem. Res. 42, 795\u2013809 (2017).","journal-title":"Neurochem. Res."},{"key":"76350_CR49","doi-asserted-by":"crossref","unstructured":"Iossa, S., Marciano, E. & Franz\u00e9, A. GJB2 gene mutations in syndromic skin diseases with sensorineural hearing loss. in Advances in Genome Science (eds. Iossa, S., Marciano, E. & Franz\u00e9, A.) 30\u201346 (BENTHAM SCIENCE PUBLISHERS, 2016).","DOI":"10.2174\/9781681081731116040004"},{"key":"76350_CR50","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/35078107","volume":"411","author":"SM Elbashir","year":"2001","unstructured":"Elbashir, S. M. et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411, 494\u2013498 (2001).","journal-title":"Nature"},{"key":"76350_CR51","doi-asserted-by":"publisher","first-page":"108811","DOI":"10.1016\/j.exer.2021.108811","volume":"213","author":"JC Youkilis","year":"2021","unstructured":"Youkilis, J. C. & Bassnett, S. Single-cell RNA-sequencing analysis of the ciliary epithelium and contiguous tissues in the mouse eye. Exp. Eye Res. 213, 108811 (2021).","journal-title":"Exp. Eye Res."},{"key":"76350_CR52","doi-asserted-by":"publisher","first-page":"597769","DOI":"10.3389\/fcell.2020.597769","volume":"8","author":"K Xu","year":"2020","unstructured":"Xu, K. et al. Local macrophage-related immune response is involved in cochlear epithelial damage in distinct Gjb2-related hereditary deafness models. Front. Cell Dev. Biol. 8, 597769 (2020).","journal-title":"Front. Cell Dev. Biol."},{"key":"76350_CR53","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nbt.3802","volume":"35","author":"SF Dowdy","year":"2017","unstructured":"Dowdy, S. F. Overcoming cellular barriers for RNA therapeutics. Nat. Biotechnol. 35, 222\u2013229 (2017).","journal-title":"Nat. Biotechnol."},{"key":"76350_CR54","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.cell.2013.06.044","volume":"154","author":"LA Gilbert","year":"2013","unstructured":"Gilbert, L. A. et al. CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes. Cell 154, 442\u2013451 (2013).","journal-title":"Cell"},{"key":"76350_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-63167-x","volume":"16","author":"D Xu","year":"2025","unstructured":"Xu, D. et al. Programmable epigenome editing by transient delivery of CRISPR epigenome editor ribonucleoproteins. Nat. Commun. 16, 7948 (2025).","journal-title":"Nat. Commun."},{"key":"76350_CR56","doi-asserted-by":"publisher","unstructured":"Munoz, A. & Morachis, J. High efficiency sorting and outgrowth for single-cell cloning of mammalian cell lines. Res. Sq. https:\/\/doi.org\/10.21203\/rs.3.rs-1463549\/v1 (2022).","DOI":"10.21203\/rs.3.rs-1463549\/v1"},{"key":"76350_CR57","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.ajhg.2020.06.011","volume":"107","author":"D Sinha","year":"2020","unstructured":"Sinha, D. et al. Human iPSC modeling reveals mutation-specific responses to gene therapy in a genotypically diverse dominant maculopathy. Am. J. Hum. Genet. 107, 278\u2013292 (2020).","journal-title":"Am. J. Hum. Genet."},{"key":"76350_CR58","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.ajhg.2018.12.019","volume":"104","author":"PK Shahi","year":"2019","unstructured":"Shahi, P. K. et al. Gene augmentation and readthrough rescue channelopathy in an iPSC-RPE model of congenital blindness. Am. J. Hum. Genet. 104, 310\u2013318 (2019).","journal-title":"Am. J. Hum. Genet."},{"key":"76350_CR59","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aat5580","volume":"11","author":"R Sharma","year":"2019","unstructured":"Sharma, R. et al. Clinical-grade stem cell-derived retinal pigment epithelium patch rescues retinal degeneration in rodents and pigs. Sci. Transl. Med. 11, eaat5580 (2019).","journal-title":"Sci. Transl. Med."},{"key":"76350_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/hgtb.2017.098","volume":"29","author":"C G\u00e1ndara","year":"2018","unstructured":"G\u00e1ndara, C., Affleck, V. & Stoll, E. A. Manufacture of third-generation Lentivirus for preclinical use, with process development considerations for translation to good manufacturing practice. Hum. Gene Ther. Methods 29, 1\u201315 (2018).","journal-title":"Hum. Gene Ther. Methods"},{"key":"76350_CR61","doi-asserted-by":"crossref","unstructured":"Doman, J.L., Raguram, A., Newby, G.A. et al. Evaluation and minimization of Cas9-independent off-target DNA editing by cytosine base editors. Nat Biotechnol 38, 620\u2013628 (2020).","DOI":"10.1038\/s41587-020-0414-6"},{"key":"76350_CR62","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1093\/bioinformatics\/btw561","volume":"33","author":"J Park","year":"2017","unstructured":"Park, J., Lim, K., Kim, J.-S. & Bae, S. Cas-analyzer: An online tool for assessing genome editing results using NGS data. Bioinformatics 33, 286\u2013288 (2017).","journal-title":"Bioinformatics"},{"key":"76350_CR63","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.neuron.2019.07.014","volume":"104","author":"R Tian","year":"2019","unstructured":"Tian, R. et al. CRISPR interference-based platform for multimodal genetic screens in human iPSC-derived neurons. Neuron 104, 239\u2013255.e12 (2019).","journal-title":"Neuron"},{"key":"76350_CR64","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41596-022-00755-x","volume":"18","author":"X Wang","year":"2023","unstructured":"Wang, X. et al. Preparation of selective organ-targeting (SORT) lipid nanoparticles (LNPs) using multiple technical methods for tissue-specific mRNA delivery. Nat. Protoc. 18, 265\u2013291 (2023).","journal-title":"Nat. Protoc."},{"key":"76350_CR65","doi-asserted-by":"publisher","first-page":"10464","DOI":"10.1021\/acsami.2c21683","volume":"15","author":"M Zhu","year":"2023","unstructured":"Zhu, M. et al. Guanidinium-rich lipopeptide-based nanoparticle enables efficient gene editing in skeletal muscles. ACS Appl. Mater. Interfaces 15, 10464\u201310476 (2023).","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"76350_CR66","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/s41587-019-0032-3","volume":"37","author":"K Clement","year":"2019","unstructured":"Clement, K. et al. CRISPResso2 provides accurate and rapid genome editing sequence analysis. Nat. Biotechnol. 37, 224\u2013226 (2019).","journal-title":"Nat. Biotechnol."},{"key":"76350_CR67","doi-asserted-by":"publisher","first-page":"C56","DOI":"10.1152\/ajpcell.00093.2022","volume":"323","author":"KM Beverley","year":"2022","unstructured":"Beverley, K. M. et al. Kir7.1 disease mutant T153I within the inner pore affects K+ conduction. Am. J. Physiol. Cell Physiol. 323, C56\u2013C68 (2022).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"76350_CR68","doi-asserted-by":"publisher","first-page":"W216","DOI":"10.1093\/nar\/gkac194","volume":"50","author":"BT Sherman","year":"2022","unstructured":"Sherman, B. T. et al. DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update). Nucleic Acids Res. 50, W216\u2013W221 (2022).","journal-title":"Nucleic Acids Res."},{"key":"76350_CR69","doi-asserted-by":"publisher","first-page":"4011","DOI":"10.1091\/mbc.e03-12-0876","volume":"15","author":"G Tai","year":"2004","unstructured":"Tai, G. et al. Participation of the syntaxin 5\/Ykt6\/GS28\/GS15 SNARE complex in transport from the early\/recycling endosome to theTrans-Golgi network. Mol. Biol. Cell 15, 4011\u20134022 (2004).","journal-title":"Mol. Biol. Cell"},{"key":"76350_CR70","doi-asserted-by":"publisher","first-page":"E716","DOI":"10.1002\/humu.21036","volume":"30","author":"S-Y Choi","year":"2009","unstructured":"Choi, S.-Y. et al. Different functional consequences of two missense mutations in the GJB2 gene associated with non-syndromic hearing loss. Hum. Mutat. 30, E716\u2013E727 (2009).","journal-title":"Hum. Mutat."},{"key":"76350_CR71","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1093\/hmg\/ddl184","volume":"15","author":"M Bicego","year":"2006","unstructured":"Bicego, M. et al. Pathogenetic role of the deafness-related M34T mutation of Cx26. Hum. Mol. Genet. 15, 2569\u20132587 (2006).","journal-title":"Hum. Mol. Genet."},{"key":"76350_CR72","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.jmb.2010.10.032","volume":"405","author":"A Oshima","year":"2011","unstructured":"Oshima, A. et al. Asymmetric configurations and N-terminal rearrangements in connexin26 gap junction channels. J. Mol. Biol. 405, 724\u2013735 (2011).","journal-title":"J. Mol. Biol."},{"key":"76350_CR73","doi-asserted-by":"publisher","first-page":"e17066","DOI":"10.1371\/journal.pone.0017066","volume":"6","author":"T Iwamori","year":"2011","unstructured":"Iwamori, T., Lin, Y.-N., Ma, L., Iwamori, N. & Matzuk, M. M. Identification and characterization of RBM44 as a novel intercellular bridge protein. PLoS One 6, e17066 (2011).","journal-title":"PLoS One"},{"key":"76350_CR74","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1534\/genetics.107.085902","volume":"179","author":"LM Turner","year":"2008","unstructured":"Turner, L. M., Chuong, E. B. & Hoekstra, H. E. Comparative analysis of testis protein evolution in rodents. Genetics 179, 2075\u20132089 (2008).","journal-title":"Genetics"},{"key":"76350_CR75","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-021-00345-1","volume":"10","author":"X Li","year":"2022","unstructured":"Li, X. et al. Structures and biological functions of zinc finger proteins and their roles in hepatocellular carcinoma. Biomark. Res. 10, 2 (2022).","journal-title":"Biomark. Res."},{"key":"76350_CR76","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1089\/thy.2018.0595","volume":"28","author":"P Str\u00f8mme","year":"2018","unstructured":"Str\u00f8mme, P. et al. Mutated thyroid hormone transporter OATP1C1 associates with severe brain hypometabolism and juvenile neurodegeneration. Thyroid 28, 1406\u20131415 (2018).","journal-title":"Thyroid"},{"key":"76350_CR77","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1210\/me.2001-0309","volume":"16","author":"F Pizzagalli","year":"2002","unstructured":"Pizzagalli, F. et al. Identification of a novel human organic anion transporting polypeptide as a high affinity thyroxine transporter. Mol. Endocrinol. 16, 2283\u20132296 (2002).","journal-title":"Mol. Endocrinol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76350-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76350-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76350-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T09:02:21Z","timestamp":1786611741000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76350-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,13]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["76350"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-76350-5","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,13]]},"assertion":[{"value":"15 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"K.S. receives honoraria for advisory board membership for Andson Biotech and Bharat Biotech. D.M.G. is a consultant for Opsis, Fujifilm-Cellular Dynamics, Inc., and Blue Rock Therapeutics. B.P. is the founder and\u00a0board member of Hubble Therapeutics. All other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"8086"}}